Midterm outcomes of isolated tricuspid valve surgery with a mini-thoracotomy and beating heart strategy

Heemoon Lee,Jihoon Kim,Ji-Hyun Jung,Jae Suk Yoo

DOI: https://doi.org/10.21037/jtd-22-1868

2023-05-09

Journal of Thoracic Disease

Abstract:Midterm outcomes of isolated tricuspid valve surgery with a mini-thoracotomy and beating heart strategy

respiratory system

What problem does this paper attempt to address?

Comparison of Clinical Outcomes and Postoperative Recovery Between Two Open Heart Surgeries:Minimally Invasive Right Subaxillary Vertical Thoracomy and Traditional Median Sternotomy

Chuan-Xian Hu,Juan Tan,Sheng Chen,Hui Ding,Zhi-Wei Xu

DOI: https://doi.org/10.1016/s1995-7645(14)60105-x

2014-01-01

Asian Pacific Journal of Tropical Medicine

Abstract:Objective: To compare the clinical outcomes of minimally invasive right subaxillary vertical thoracotomy and traditional median stemotomy through right atrium in treatment of common congenital heart diseases. Methods: Clinical data of 59 cases of common congenital heart diseases treated with minimally invasive right axillary vertical thoracotomy from May, 2011 to February, 2013 and 77 cases of same diseases with traditional median stemotomy in the past three years were retrospectively analyzed, including atrial septal defect, membranous ventricular septal defect and partial endocardial cushion defect. The results were compared from the two groups, including the time for operation and cardiopulmonary bypass, amount of blood transfusion, postoperative drainage, ventilation time, hospital stay, and prognosis. Results: No severe complications happened in both groups, like deaths or secondary surgery caused by bleeding. No significant differences were in CPB time and postoperative ventilator time between groups (P>0.05), while for all of the operative time, the length of incision, postoperative drainage and hospital stay, minimally invasive right axillary vertical thoracotomy was superior to median stemotomy, with statistically significant differences (P<0.05). In six month followup after operation, no complications of residual deformity and pericardial effusion were found in both groups by doing echocardiography, but mild pectus carinatum was found in 8 patients in the traditional median sternotomy group (traditional group), whereas patients in another group were well recovered. Conclusions: Minimally invasive right subaxillary vertical thoracotomy for common congenital heart diseases is as safe as traditional median stemotomy, without the increasing incidence of postoperative complications. Additionally, compared with traditional median stemotomy, minimally - invasive right subaxillary vertical thoracotomy is better in the aspects of hidden incision, appearance, and postoperative recovery.
Simplified Minimally Invasive Beating Heart Technique for Redo Isolated Tricuspid Valve Surgery

Shuyang Lu,Kai Song,Wangchao Yao,Limin Xia,Lili Dong,Yongxin Sun,Tao Hong,Shouguo Yang,Chunsheng Wang

DOI: https://doi.org/10.21203/rs.3.rs-18705/v1

2020-01-01

Abstract:Abstract BackgroundRedo isolated tricuspid valve surgery has been associated with a high morbidity and mortality, and its optimal timing of surgical intervention remains controversial. Hence, we reviewed our early and midterm results with a simplified minimally invasive beating heart technique for isolated redo tricuspid valve surgery in patients at high risk.MethodsBetween June 2016 and August 2017, a total of 14 consecutive patients underwent isolated tricuspid valve operations after previous cardiac operations with minimally invasive beating heart technique through a right lateral thoracotomy in our center. Mean patient age was 54.0 ± 8.3 years, and 9 patients (64.3%) were women. Mean preoperative EuroSCORE was 8.1 ± 1.3 (6 to 11). Previous cardiac operations included 6 patients (42.9%) with mitral valve replacement, 1 patient (7.1%) with mitral valve replacement and tricuspid valve repair, 1 patient (7.1%) with tricuspid valve replacement, 5 patients (35.7%) with mitral valve and aortic valve replacement, and 1 patient (7.1%) with Ebstein repair. Midterm follow-up was complete for 12 patients (85.7%).ResultsBoth in-hospital and thirty-day mortalities were 0%. Tricuspid valve replacement with bioprosthesis was performed in 12 patients (85.7%), and the remaining 2 patients (14.3%) underwent tricuspid repair (annuloplasty and leaflets reconstruction). Mean cardiopulmonary bypass time was 55.6 ± 10.7 minutes. Overall in-hospital duration and intensive care unit (ICU) time were 11.6 ± 8.8 days, 3.9 ± 2.8 days, respectively. Postoperative complications included 2 patients (1.4%) with prolonged ventilation, and 2 patients (1.4%) with acute kidney injury. There were no postoperative cerebrovascular accidents, myocardial infarctions, reoperations for bleeding, or deep wound infections. All patients were discharged uneventful. Except 2 patients lost follow-up, there were no adverse cardiovascular events and deaths occurred in other patients.ConclusionsSimplified minimally invasive beating heart technique for redo tricuspid valve surgery is both feasible and safe, and the early and midterm results are excellent.
Simplified, Minimally Invasive, Beating-Heart Technique for Redo Isolated Tricuspid Valve Surgery.

Shuyang Lu,Kai Song,Wangchao Yao,Limin Xia,Lili Dong,Yongxin Sun,Tao Hong,Shouguo Yang,Chunsheng Wang

DOI: https://doi.org/10.1186/s13019-020-01192-1

2020-01-01

Journal of Cardiothoracic Surgery

Abstract:Abstract Background Redo isolated tricuspid valve surgery is associated with a high morbidity and mortality, and its optimal timing remains controversial. Hence, here we reviewed the early and midterm results of simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery in patients at high risk. Methods A total of 32 consecutive patients underwent a redo isolated tricuspid valve surgery using minimally invasive, beating-heart technique through a right lateral thoracotomy in our center between June 2016 and April 2020. The mean age of patients was 57.4 ± 8.3 years, and 18 patients (56.3%) were women. The mean preoperative EuroSCORE was 7.8 ± 1.4 (range: 6–11). Follow-up was 87.1% complete, with a mean duration of 26.3 ± 12.3 months. Results Both in-hospital and 30-day mortalities were 3.1%. Tricuspid valve replacement with bioprosthesis was performed in 30 patients (93.8%), and the remaining two patients (6.2%) underwent tricuspid repair (annuloplasty and leaflet reconstruction). The mean cardiopulmonary bypass time was 81.5 ± 29.0 min. The overall in-hospital duration and intensive care unit (ICU) times were 13.6 ± 7.6 days and 4.1 ± 2.8 days, respectively. Postoperative complications included prolonged ventilation in six patients (18.8%), acute kidney injury in three patients (9.4%), and neurologic event, wound infection, or permanent third-degree atrioventricular block, in one patient (3.1%) each. A total of 96.9% patients were discharged uneventfully. Four patients were lost to follow-up; there were no midterm deaths in patients who were followed up. Conclusions Simplified, minimally invasive, beating-heart technique for redo tricuspid valve surgery is both feasible and safe, and the early and midterm results are excellent.
Long-term outcomes of minimally invasive concomitant mitral and tricuspid valve surgery with surgical ablation

Sungsil Yoon,Kitae Kim,Jae Suk Yoo,Joon Bum Kim,Cheol Hyun Chung,Sung-Ho Jung

DOI: https://doi.org/10.1093/icvts/ivae146

2024-09-04

Abstract:Objectives: We compared the outcomes of a right mini-thoracotomy (RMT) versus those of a sternotomy for concomitant mitral and tricuspid valve surgery and surgical ablation. Methods: We analysed patients who underwent concomitant mitral and tricuspid valve surgery and surgical ablation at a single institution (mean follow-up: 7 years) after propensity score matching. The primary and secondary outcomes were all-cause death, composite major adverse events (including stroke, reoperation, readmission, permanent pacemaker insertion) and recurrence of atrial fibrillation (A-fib). A subgroup analysis was performed. Results: A total of 797 procedures (mean age: 61.6 years; RMT: 45.2%; female: 66.5%; mitral valve repair: 33.6%) were done; 267 pairs were matched. The 5- and 10-year overall survival in the matched cohort was 92.7% and 86.9% for the RMT group and 92.1% and 83.1% for the sternotomy group (P = 0.879). Significant differences were not observed in major adverse events (P = 0.273; hazard ratio: 0.76) and A-fib recurrence (P = 0.080; hazard ratio: 0.72). The RMT group had lower rates of postoperative low cardiac output syndrome (P = 0.019) and acute renal failure (P = 0.003). Atrial fibrillation high-risk factors (including long-standing A-fib, enlarged left atrium, old age) exhibited significant interactions (P for interaction = 0.002) with the approach regarding A-fib recurrence. Conclusions: In this study, an RMT exhibited no significant differences in long-term outcomes compared to a sternotomy, but it could remain a clinically reasonable option. Patients with a high risk of A-fib may have favourable ablation outcomes with a sternotomy.
Early and mid-term outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation induced by atrial fibrillation

Eun Chae Kim,Nazla Amanda Soehartono,Sue Hyun Kim,Yeiwon Lee,Suk Ho Sohn,Ho Young Hwang,Kyung Hwan Kim,Jae Woong Choi

DOI: https://doi.org/10.21037/jtd-23-1776

2024-04-30

Journal of Thoracic Disease

Abstract:Keywords: Atrial fibrillation (AF); tricuspid valve regurgitation; tricuspid surgery

respiratory system
Minimally Invasive Isolated Tricuspid Valve Repair after Left-Sided Valve Surgery: A Single-Center Experience.

Xiaoyi Dai,Peng Teng,Sihan Miao,Junnan Zheng,Wei Si,Qi Zheng,Ke Qin,Liang Ma

DOI: https://doi.org/10.3389/fsurg.2022.837148

IF: 1.8

2022-01-01

Frontiers in Surgery

Abstract:Background:Tricuspid regurgitation after left-sided valve surgery was associated with terrible outcomes and high perioperative mortality for surgical treatment. In current years, minimally invasive isolated tricuspid valve repair is increasingly performed in our institution to address tricuspid regurgitation.Methods:Thirty-seven consecutive patients with previous left-sided valve surgery underwent minimally invasive isolated tricuspid valve repair in our institution between November 2017 and December 2020. Twenty-nine patients(78.4%) were women and the mean age of patients was 58.4 ± 8.5 years. Follow-up was 100% complete with a mean follow-up time of 17.2 ± 9.5 months.Results:Both the in-hospital and 30-day mortalities were 2.7%. The overall NYHA class had improved significantly during the follow-up (p < 0.001). The grade of TR had decreased before discharge (p < 0.001) and during the follow-up (p < 0.001) compared with the preoperative level although severe TR was recurrent in one patient.Conclusions:Minimally invasive isolated tricuspid valve repair has acceptable early and midterm outcomes, may be the preferred surgical option to address tricuspid regurgitation after previous left-sided valve surgery when it is feasible.
Mid-term outcomes of isolated tricuspid valve surgery according to preoperative clinical and functional staging

Alessandra Sala,Roberto Lorusso,Edoardo Zancanaro,Davide Carino,Marta Bargagna,Arturo Bisogno,Elisabetta Lapenna,Stefania Ruggeri,Roberta Meneghin,Davide Schiavi,Nicola Buzzatti,Paolo Denti,Fabrizio Monaco,Eustachio Agricola,Francesco Maisano,Ottavio Alfieri,Alessandro Castiglioni,Michele De Bonis

DOI: https://doi.org/10.1093/ejcts/ezac172

2022-07-11

Abstract:Objectives: This study aimed at assessing mid-term outcomes of patients undergoing isolated tricuspid valve (TV) surgery based on a preoperative baseline clinical and functional classification. Methods: All patients treated with isolated TV repair or replacement from March 1997 to May 2020 at a single institution were retrospectively reviewed and assessed for mid-term postoperative outcome according to a novel classification [stages 1-5 related to the absence or presence and extent of right heart failure (RHF)]. Kaplan-Meier survival curves were used to estimate mid-term survival. Competing risk analysis for time to cardiac death and hospitalizations for RHF were also carried out. Results: Among the 172 patients included, 129 (75%) underwent TV replacement and 43 (25%) TV repair. At follow-up (median 4.2 years [2.1-7.5]), there were 23 late deaths. At 5 years, overall survival was 100% in stage 2, 88 ± 4% in stage 3 and 60 ± 8% in stages 4-5 (P = 0.298 and P = 0.001, respectively). Cumulative incidence function of cardiac death at 5 years was 0%, 8.6 ± 3.76% and 13.2 ± 5% for stages 2, 3 and 4 and 5, respectively. At follow-up, cumulative incidence function of re-hospitalizations for RHF was 0% for stage 2, 20 ± 5% for stage 3 and 20 ± 6.7% for stages 4 and 5 (P = 0.118 and P = 0.039, respectively). Conclusions: Both short- and mid-term outcomes support early referral for surgery in isolated TV disease, with excellent survival at 5 years and no further hospitalizations for RHF.
Minimally Invasive Valve Replacement for Late Tricuspid Regurgitation after Left-Sided Valve Surgery

Jinmiao Chen,Wenrui Ma,Yang Ming,Wenshuo Wang,Shun Liu,Ye Yang,Yi Lin,Lai Wei,Chunsheng Wang

DOI: https://doi.org/10.1016/j.athoracsur.2020.08.091

IF: 5.113

2021-01-01

The Annals of Thoracic Surgery

Abstract:Objective: To examine the short-term outcomes of minimally invasive reoperation for severe tricuspid regurgitation after left-sided valve surgery. Methods: From January 2015 to December 2018, a total of 89 patients with severe tricuspid regurgitation after left-sided valve surgery received reoperation in Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University were included in this study. There were 21 males and 68 females, aging of (56.4±7.9) years (range: 41 to 74 years). The interval between previous left-sided valve surgery and tricuspid reoperation was (14.1±6.1) years (range: 4 to 33 years). A combination of multiple minimally invasive techniques were adopted, including endoscopy-assist right minithoracotomy approach, peripheral cannulation strategy with the vacuum-assist single venous drainage technique, heart beating technique, and temporary percutaneous pacemaker implantation, with a concomitant enhancement in preoperative right cardiac function optimization. Results: All patients received minimally invasive isolated tricuspid valve replacement (n=81) or tricuspid valve repair (n=8). After the application of multiple minimally invasive techniques, the operative mortality rate was only 3.4% (3/89). The causes of death were progressive right heart failure with multiorgan failure (n=1) and low cardiac output associated with postoperative bleeding (n=2). Regarding to the perioperative complications, renal replacement therapy rate was 5.6% (5/89), permanent pacemaker implantation rate was 1.1% (1/89), and the incidence of stroke was 0. Mechanical ventilation time was 24(24) hours, ICU stay time was 2.5 (3.0) days (M(Q(R))). During the short-term follow-up, there were no case of severe tricuspid regurgitation, 2 cases of moderate regurgitation, 4 cases of mild-to-moderate regurgitation. Conclusions: For severe tricuspid regurgitation after left-sided valve surgery, the advanced minimally invasive techniques can significantly reduce the operative mortality and morbidity. Minimally invasive bioprosthetic tricuspid valve replacement is a reliable alternative for severe tricuspid regurgitation after left-sided valve surgery.
Minimally Invasive Isolated Tricuspid Valve Repair: the Trend for Redo Tricuspid Valve Surgery

Xiaoyi Dai,Peng Teng,Sihan Miao,Wei Si,Qi Zheng,Ke Qin,Liang Ma

DOI: https://doi.org/10.21203/rs.3.rs-410036/v1

2021-01-01

Abstract:Abstract Background: Tricuspid regurgitation after left-sided valve surgery was associated with terrible outcomes and high perioperative mortality for redo surgical treatment. In current years, minimally invasive redo isolated tricuspid valve repair is increasingly performed in our institution to address tricuspid regurgitation. Methods: Thirty-seven consecutive patients with previous left-sided valve surgery underwent minimally invasive redo isolated tricuspid valve repair in our institution between November 2017 and December 2020. Twenty-nine patients(78.4%) were women and the mean age of patients was 58.4±8.5 years. Follow-up was 100% complete with a mean follow-up time of 16.8±9.4 months.Results: Both the in-hospital and 30-day mortalities were 2.7%. The overall NYHA class had improved significantly during the follow-up(p＜0.001). The grade of TR had decreased before discharge(p＜0.001) and during the follow-up(p＜0.001) compared with the preoperative level although severe TR was recurrent in one patient.Conclusions: Minimally invasive redo isolated tricuspid valve repair has remarkable early and midterm outcomes, may be the preferred surgical option to address tricuspid regurgitation after previous left-sided valve surgery when it is feasible.
Benefits Of A Right Anterolateral Minithoracotomy Rather Than A Median Sternotomy In Isolated Tricuspid Redo Procedures

Aikebaier Maimaiti,Lai Wei,Ye Yang,Huan Liu,Chunsheng Wang

DOI: https://doi.org/10.21037/jtd.2017.04.50

2017-01-01

Journal of Thoracic Disease

Abstract:Background: To compare results of tricuspid valve (TV) reoperation between incision via a right anterolateral minithoracotomy (RAMT) and median sternotomy (MS).Methods: We performed a retrospective analysis of 49 patients who underwent isolated TV surgery as a reoperation at our institution between 2006 and 2015. Previous cardiac operations included mitral, aortic, and TV surgeries, atrial septal defect repair, and pericardiectomy. The mean age of the patients was 51.9 +/- 12.8 years, 14 (28%) were male and 35 (72%) were female. Follow-up was 95% (38/40) complete, with a mean duration of 41.3 +/- 19.5 months.Results: Perioperative demographic and laboratory tests did not show any significant differences between the RAMT and MS groups. The drainage volume, total red cell unit, total serum volume and platelet were significantly different 1150 +/- 803.5/2,270 +/- 1,920, 4.8 +/- 4.1/8.7 +/- 8.9, 478.2 +/- 488.9/950.0 +/- 857.6, 0.04 +/- 0.21/0.38 +/- 0.64 (P< 0.05), while other perioperative data were similar. There were no significant differences in early postoperative death and complications between the RAMT and MS groups. A multivariate linear regression analysis predicted that serum creatinine (Scr), age, and MS group were independent risk factors for bleeding. The Cox regression demonstrated that the MS group had a longer drainage duration (P< 0.05) and had a relative hazardous risk (HR) of 2.691 (1.328, 5.450 CI) compared with the RAMT group.Conclusions: The RAMT approach is an alternative, safe, and feasible procedure for isolated TV reoperation. It has the advantages of less drainage and reduced requirement for blood products.
Early and Mid-Term Outcomes of Isolate Mitral Valve Repair Through Minimal Invasive Versus Median Sternotomy Ap-Proach: a Propensity-Matched Analysis

Zhou Tianyu,Li Jun,Lai Hao,Sun Yongxin,Zhu Kai,Dong Lili,Chen Haiyan,Wei Lai,Zhao Dong,Ding Wenjun,Hong Tao,Wang Chunsheng

DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2018.01.005

2018-01-01

Abstract:Objective The aim of the study was to compare the early and mid-term outcomes of isolate mitral valve repair through minimal invasive and median sternotomy approach .Methods From July 2009 to December 2015, 329 patients under-went minimal invasive isolated mitral valve repair through right thoracic approach at our institution .The mean age was(48 ±14) years(15-78 years), 202 patients(61.4％) were male and 137 patients(41.6％) were in NYHA class Ⅲ-Ⅳ.570 patients underwent isolate mitral valve repair through median sternotomy in the same period .Propensity score matching identify 248 pa-tient pairs with similar preoperative characteristics .Early and mid-term outcomes were compared between propensity-matched groups.Results After propensity matching, the mean cardiopulmonary bypass time[(91 ±27)min vs.(76 ±27)min, P<0.05] and aorta cross clamp time[(52 ±18)min vs.(43 ±15)min, P<0.05] were significantly longer in minimal invasive group.24 hours drainage volume was significantly less[(353 ±329)ml vs.(446 ±356)ml, P <0.05] and patients need transfusion was significantly fewer(22.2％ vs 31.5％, P<0.05) in minimal invasive group.Incidence of stroke, poor wound healing, renal failure requiring hemodialysis and tracheotomy were similar between the two groups(P>0.05).There were two in-hospital death in minimal invasive group(respiratory failure) and median sternotomy group(low cardiac output syndrome), respectively.Follow-up was 91％ complete and the mean follow-up time was(28 ±21) months(3-89 months).At 7 year after surgery, overall survival were 99％and 100％(P>0.05) in minimal invasive group and median sternotomy group, respective-ly.Freedom from reoperation were 100％ and 95％(P>0.05) and freedom from recurrent mitral regurgitation were 95％ and 90％(P>0.05).Conclusion Minimal invasive mitral valve repair was safe, effective and provide equivalent mid-term out-comes compared to median sternotomy approach .Minimal invasive surgery provided cosmetic benefits , decreased postoperative trauma.As the accumulation of clinical experience, complex repair is feasible through minimal invasive surgery.Adoption of minimal invasive surgery will increase the acceptance of early intervention strategy among asymptomatic MR patients and thus improve late outcomes and life quality .
Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring

Heemoon Lee,Jihoon Kim,Ji-Hyun Jung,Jae Suk Yoo

DOI: https://doi.org/10.1093/icvts/ivae131

2024-07-03

Abstract:Objectives: The Tri-Ad Adams tricuspid annuloplasty ring is a recent innovative prosthesis characterized by a semi-rigid central component and fully flexible extremities. The goal of this study was to assess the short-term and mid-term results following implantation of the Tri-Ad Adams ring. Methods: A retrospective analysis was conducted on patients who underwent tricuspid annuloplasty using the Tri-Ad Adams ring between August 2016 and October 2021. Results: Our study enrolled a total of 248 participants. The median age was 64.0 (interquartile range: 56.0-71.5) years. The median EuroSCORE II was 4.3% (2.7-7.5%), with 37 patients (14.9%) having a history of cardiac operations. Tricuspid regurgitation of grade 2-3 was observed in 63.7% of cases, and the median tricuspid annular diameter was 3.3 (2.8-3.6) cm. Concurrent procedures included mitral valve replacement (n = 160, 64.5%), mitral valve repair (n = 75, 30.2%), aortic valve replacement (n = 72, 29.0%) and the maze procedure (n = 170, 68.5%). Immediate postoperative tricuspid regurgitation≥moderate was present in 1 patient (0.4%). Early death occurred in 14 patients (5.6%). Major complications included low cardiac output syndrome (n = 18, 0.3%), acute kidney injury (n = 14, 5.6%) and permanent pacemaker placement (n = 15, 6.0%). According to the Kaplan-Meier analysis, the 4-year rates of freedom from overall mortality and moderate-to-severe tricuspid regurgitation were 96.9% and 91.6%, respectively. There were no incidents of tricuspid valve reoperations, ring detachment or significant tricuspid stenosis (trans-tricuspid valve gradient ≥ 5 mmHg). Conclusions: Tricuspid annuloplasty utilizing the Tri-Ad Adams ring demonstrated favourable outcomes in both the early and midterm periods. Further studies are warranted to confirm the long-term results.
Safety and efficacy of total thoracoscopic surgery for patients with tricuspid regurgitation and reduced right ventricular function after left heart valves replacement: a retrospective comparative study

Zhiqin Lin,Zheng Xu,Xiujun Chen,Feng Lin,Liangwan Chen,Xiaofu Dai

DOI: https://doi.org/10.1186/s12872-023-03428-z

IF: 2.174

2023-08-15

BMC Cardiovascular Disorders

Abstract:Tricuspid valve surgery is the standard treatment for tricuspid valve disease refractory to pharmacologic therapy. However, patients with tricuspid regurgitation after previous left heart valves replacement with reduced right ventricular (RV) function are at greater risk of surgery. We compared the clinical outcomes of tricuspid valve replacement in this subgroup of patients through mini-thoracotomy and conventional full-sternotomy approach.

cardiac & cardiovascular systems
Mid-term Outcomes of Transventricular Valvotomy Approach for Initial Treatment of Pulmonary Atresia with Intact Ventricular Septum

Chen Gang,Wu Lin,Liu Fang,Ye Ming,Mi Yaping,Jia Bing

DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2016.02.002

2016-01-01

Abstract:Objective To explore the mid-term surgical outcomes of transventricular pulmonary valvotomy (TPV) in patients with pulmonary atresia-intact ventricular septum (PA/IVS) and non-right ven tricular dependant coronary circulation.Methods The clinical data were reviewed retrospectively for 21 patients with PA/IVS and non-right ventricular dependant coronary circulation undergoing TPV from 2010-2013 at our center.The mean body weight was (3.2 ± 0.7) kg and mean age (16 ± 8) days.The Z-score of tricuspid valve ranged from-2.5～2.2(-0.9 ± 0.4).TPV procedure was guided by the Micro-TEE probe for confirming the position of valvular perforation.The follow-up period was over 12 months.They were divided into two groups of Bi-ventricle repair (BVR) and non-BVR.And the parameters of percutaneous saturation,Z-score of tricuspid valve and reintervention profiles were collected at 3,6,12,24,36 and 48 months after procedure.Results One early death occurred postoperatively due to severe hyoxemia and parental refusal of reoperation.And 12 patients finally underwent BVR.Among 8 patients in non-BVR group,5/8 underwent one-and-half ventricle repair while the remainder were still followed up after TPV.The mean follow-up time was (32.3 ± 10.3) (12～60) months without late death.Early reintervention was required in 4 patients (20％).One in BVR group underwent percutaneous pulmonary valve balloon dilation for residual obstruction.And 3 in one-BVR group developed hyoxemia requiring modified B-T shunts (n =2) and patent ductus arteriosus (PDA) stenting (n =1) (8.3％ vs 37.5％,P＜0.01).At Day 30 post-operation,saturation was higher in BVR group than that in non-BVR group.And the mean values were (88 ± 6) and (74 ± 7) (P＜0.05) while PGE1 maintenance time was also shorter in BVR group than that in non-BVR group.And the mean values were (5.6 ± 2.2) and (7.4 ± 4.2) respectively (P＜0.05).Z-score was significantly greater in BVR group than that in non-BVR group.And the mean Z-scores were (-0.5 ± 0.3) and (-1.5-0.6) respectively (P =0.01).The freedom from reoperation was 80％,70％ and 35％ at 6 months,1 and 3 years respectively.And the reoperative rates of two groups were both 75％.In BVR group,9/12 underwent atrial septal defect (ASD) device closure by catheter or surgery.In non-BVR group,5 underwent bidirectional Glenn shunt for ASD closure and 1 had reconstruction of right ventricle outflow for muscular obstruction.The mean Z-score ranged from-2～ 2.2 (-0.5 ±0.4),-2.1～2.2(-0.5 ±0.3),-2.3～2.0(-0.2 ±0.3),-0.4～2.2(0.5 ±0.8),-0.5～2.2 (0.6 ±0.8) and-0.2～2.2(0.7 ± 0.3) at 3 months,6 months,1year,2 years,3 and 4 years post-TPV.Conclusions The outcomes of a hybrid approach are excellent for improving the function of right ventricle in patients with PA/IVS.And TPV may be used alternatively via a transcatheter approach.
Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation

Daisuke Kaneyuki,Andrew M. Jordan,Jake L. Rosen,Thomas Reese Macmillan,Rohinton J. Morris,Vakhtang Tchantchaleishvili

DOI: https://doi.org/10.1055/a-2300-6791

2024-05-04

The Thoracic and Cardiovascular Surgeon

Abstract:Background Severe tricuspid regurgitation (TR) adversely affects long-term survival; however, isolated tricuspid valve (TV) surgery has been rarely performed due to high operative mortality. In addition, the previous literature included heterogeneous TR etiologies. Therefore, we aimed to elucidate early and long-term outcomes of isolated TV surgery for functional TR. Methods An electronic search was performed to identify all relevant studies. Baseline characteristics, perioperative variables, and clinical outcomes were extracted and pooled for meta-analysis. Results This meta-analysis included seven studies. Pooled analyses showed that 68% (35, 89) of patients had preoperative atrial fibrillation or flutter, and 58% (11, 94) had a history of left-sided valve surgery. Seventy-three percent (65, 80) of patients had at least one physical exam finding of right-sided heart failure, and 57% (44, 69) were in New York Heart Association class III or IV. TV replacement was more common than repair. In TV replacement, bioprosthetic valve (39%, 13, 74) was more common than mechanical prosthesis (22%, 18, 26). The early mortality rate was 7%. Twenty percent of patients required a permanent pacemaker postoperatively. The overall 1- and 5-year survival rates were 84.5 and 69.1%, respectively. Conclusion More than half of the patients who underwent isolated TV surgery for functional TR had undergone left-sided valve surgery and had significant heart failure symptoms at the time of surgery. Further studies on the surgical indication for concomitant TV surgery at the time of left-sided valve surgery and the appropriate timing of surgery for isolated functional TR are needed to improve survival. Received: 29 December 2023 Accepted: 03 April 2024 Accepted Manuscript online: 05 April 2024 Article published online: 03 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

surgery,cardiac & cardiovascular systems,respiratory system
Mini-invasive Surgical Instruments in Transaortic Myectomy for Hypertrophic Obstructive Cardiomyopathy: a Single-Center Experience with 168 Cases

Qiang Ji,Yu Lin Wang,Ye Yang,Hao Lai,Wen Jun Ding,Li Min Xia,Chun Sheng Wang

DOI: https://doi.org/10.1186/s13019-021-01403-3

2021-01-01

Journal of Cardiothoracic Surgery

Abstract:Abstract Background Although septal myectomy is a standard strategy for managing patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms, so far, only a few experienced myectomy centers exist globally. Mainly, this can be explained by the many technical challenges presented by myectomy. From our clinical experience, applying the mini-invasive surgical instruments during myectomy potentially reduces the technical difficulty. This study reports the preliminary experience regarding transaortic septal myectomy using mini-invasive surgical instruments for managing patients with HOCM and drug-refractory symptoms; also, we evaluate the early results following myectomy. Methods Between March 2016 and March 2019, consecutive HOCM patients who underwent isolated transaortic septal myectomy using the mini-invasive surgical instruments were enrolled in this analysis. Intraoperative, in-hospital and follow-up results were analyzed. Results We included 168 eligible patients (83 males, mean 56.8 ± 12.3 years). The midventricular obstruction was recorded in 7 (4.2%) patients. All patients underwent transaortic septal myectomy with a mean aortic cross-clamping time of 36.0 ± 8.1 min. During myectomy, 9 (5.4%) patients received repeat aortic cross-clamping. Surgical mortality was 0.6%. Notably, 5 (3.0%) patients developed complete atrioventricular block, they needed permanent pacemaker implantation. The median follow-up time was 6 months; however, no follow-up deaths occurred with a significant improvement in New York Heart Association functional status. We reported a sharp decrease in the maximum gradients from the preoperative value (11.6 ± 7.4 mmHg vs. 94.4 ± 22.6 mmHg, p < 0.001). The median degree of mitral regurgitation fell to 1.0 (vs. 3.0 preoperatively, p < 0.001) with a significant reduction in the proportion of moderate or more regurgitation (1.2% vs. 57.7%, p < 0.001). Conclusions Mini-invasive surgical instruments may be beneficial in reducing the technical challenges of transaortic septal myectomy procedure. Of note, transaortic septal myectomy using the mini-invasive surgical instruments may present with favorable results.
Isolated Reoperation for Tricuspid Regurgitation after Left-Sided Valve Surgery: Technique Evolution

Jinmiao Chen,Kui Hu,Wenrui Ma,Minzhi Lv,Yu Shi,Ju Liu,Lai Wei,Yi Lin,Tao Hong,Chunsheng Wang

DOI: https://doi.org/10.1093/ejcts/ezz160

IF: 4.534

2019-01-01

European Journal of Cardio-Thoracic Surgery

Abstract:OBJECTIVES:This study aimed to compare the isolated replacement and repair of severe tricuspid regurgitation after left-sided valve surgery (LSVS) and to report the evolution of this surgical technique.METHODS:From January 2005 to August 2018, 118 patients underwent isolated tricuspid valve replacement (iTVR, n = 93) or repair (iTVr, n = 25) for severe tricuspid regurgitation after LSVS. The surgical protocol at our institution has significantly changed since 2015, implementing the right thoracotomy approach (95.5%) and peripheral cannulation strategy with the vacuum-assist single venous drainage technique (93.2%) with a concomitant enhancement in preoperative right heart function optimization. Patients were followed up for 32.5 ± 34.6 (1.6-158.7) months.RESULTS:The operative mortality rate was 8.5% (8.6% in iTVR and 8.0% in iTVr, P = 0.924) with a significant decrease from 23.3% (2005-2014) to 3.4% (2015-2018) (P < 0.001), which was associated with preoperative New York Heart Association functional class IV [odds ratio (OR) 14.73, 95% confidence interval (CI) 2.68-80.90; P = 0.002] and anaemia (OR 6.60, 95% CI 1.03-42.22; P = 0.046). After adjusting the logistic regression model, the vacuum-assist single venous drainage technique was also associated with lower operative mortality and composite adverse outcomes. The overall 1- and 5-year survival rates were 91.5% (95% CI 84.8-95.3%) and 77.9% (95% CI 60.0-88.3%), respectively, and no difference was found between the iTVR and iTVr groups (P = 0.813).CONCLUSIONS:Isolated tricuspid valve reoperation for severe tricuspid regurgitation after LSVS is historically a high-risk procedure, but satisfactory results are achievable with advanced surgical techniques and improved perioperative management. Bioprosthetic iTVR is a reliable alternative for severe tricuspid regurgitation after LSVS.
Combined Mitral And Aortic Valve Procedure Via Right Mini-Thoracotomy Versus Full Median Sternotomy Insights From A Single-Center Study Of Propensity-Matched Data

Dong Zhao,Lai Wei,Shijie Zhu,Zhiqi Zhang,Huan Liu,Ye Yang,YuLin Wang,Qiang Ji,ChunSheng Wang

DOI: https://doi.org/10.1536/ihj.18-186

2019-01-01

International Heart Journal

Abstract:Data involving combined mitral and aortic valve procedure via the right mini-thoracotomy approach are very limited. This single-center propensity-matching study aimed to evaluate early clinical outcomes of patients who underwent combined mitral and aortic valve procedure via right mini-thoracotomy versus full median sternotomy.From January 2013 to December 2016, 926 eligible patients in our center were identified for this study. After propensity score-matching, 91 pairs of patients were entered into a RT group (right mini-thoracotomy surgery) or a FS group (full median sternotomy surgery). In-hospital and follow-up clinical outcomes were investigated and analyzed.Patients in the RT group received similar surgical mortality as patients in the FS group (1.1% versus 2.2%, P > 0.05). Patients in the RT group as compared with the FS group were less likely to receive postoperative new onset of atrial fibrillation and red cell transfusion (11.0% versus 25.3%, P = 0.012; 17.6% versus 37.4%, P = 0.003, respectively), but they shared similar incidences of other major postoperative morbidity. Patients in the RT group as compared with the FS group experienced 6-minute longer aortic cross-clamping times and 9-minute longer cardiopulmonary bypass times, but received shorter intensive care unit stay and postoperative hospitalization time. No repeat valve operation, peri-prosthetic leak, or moderate or severe mitral valve regurgitation following valvuloplasty were observed in either group before discharge and also within one year of surgery.In primary, isolated, combined mitral and aortic valve procedure, a right mini-thoracotomy approach may be utilized with accepted early clinical outcomes, and may be considered as a feasible alternative to the approach of full median sternotomy.
Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes

Joon Bum Kim,Dong Gon Yoo,Gwan Sic Kim,Hyun Song,Sung-Ho Jung,Suk Jung Choo,Cheol Hyun Chung,Jae Won Lee

DOI: https://doi.org/10.1136/heartjnl-2011-300403

IF: 5.7

2011-09-19

Heart

Abstract:BACKGROUND: The decision to repair mild-to-moderate functional tricuspid regurgitation (TR) during left-side heart surgery remains controversial. Objectives To avoid heterogeneity in patient population, patients with TR undergoing isolated mechanical mitral valve (MV) replacement for rheumatic mitral diseases were evaluated.METHODS: Between 1997 and 2009, 236 patients with mild-to-moderate functional TR underwent first-time isolated mechanical MV replacement for rheumatic mitral diseases with (n=123; repair group) or without (n=113; non-repair group) tricuspid valve (TV) repair. Survival, valve-related complications, and TV function in these two groups were compared after adjustment for baseline characteristics using inverse-probability-of-treatment weighting.RESULTS: Follow-up was complete in 225 patients (95.3%) with a median follow-up of 48.7 months (IQR 20.2-89.5 months), during which time 991 echocardiographic assessments were done. Freedom from moderate-to-severe TR at 5 years was 92.9±2.9% in the repair group and 60.8±6.9% in the non-repair group (p<0.001 and 0.048 in crude and adjusted analyses, respectively). After adjustment, both groups had similar risks of death (HR=0.57, p=0.43), tricuspid reoperation (HR=0.10, p=0.080) and congestive heart failure (HR=1.12, p=0.87). Postoperative moderate-to-severe TR was an independent predictor of poorer event-free survival (HR=2.90, p=0.038).CONCLUSIONS: These findings support the strategy of correcting mild-to-moderate functional TR at the time of MV replacement to maintain TV function and improve clinical outcomes.

cardiac & cardiovascular systems
Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center

Suhua Zang,Shengwei Bai,Panyang Li,Xiaoyue Fan,Yang Liu,Weihua Zhang,Donghai Liu,Chenhui Qiao,Hao Xu,Xin Zhang

DOI: https://doi.org/10.1016/j.hlc.2023.11.008

2024-01-01

Abstract:OBJECTIVES: Previous studies have reported satisfactory long-term results of mitral valve (MV) repair for rheumatic mitral disease. However, the effects of this procedure in isolated rheumatic mitral stenosis remain unclear. In addition, protective effects of MV repair on cardiac function have not been verified in rheumatic MV disease. This study retrospectively evaluated early mortality and mid-term results of MV repair for isolated rheumatic mitral stenosis in a mid-volume cardiac centre, and explored the effects of this procedure on cardiac function.METHODS: Between January 2015 and May 2021, 360 patients with isolated rheumatic mitral stenosis and combined (concomitant) atrial fibrillation (AF) underwent MV repair (100 patients) or MV replacement (260 patients). Perioperative characteristics were compared between the two groups and a regression analysis for early mortality and mid-term left ventricular ejection fraction was conducted. In addition, mid-term survival was compared between the two groups.RESULTS: Baseline characteristics of the two groups were balanced after matching. Compared with patients in the replacement group, patients with MV repair had a lower occurrence of postoperative hypotension and AF. There was no difference in early mortality or mid-term survival between the two groups. However, MV repair was associated with a higher mid-term left ventricular ejection fraction. During follow-up, four thromboembolic events and four haemorrhagic events occurred in the replacement group. No blood coagulation-related complications occurred in the repair group.CONCLUSION: Mitral valve repair for isolated rheumatic mitral stenosis and concomitant AF was feasible in a mid-volume cardiac centre, with satisfactory perioperative results and mid-term outcomes. Furthermore, this procedure preserved mid-term left ventricular systolic function.

cardiac & cardiovascular systems

Midterm outcomes of isolated tricuspid valve surgery with a mini-thoracotomy and beating heart strategy

Comparison of Clinical Outcomes and Postoperative Recovery Between Two Open Heart Surgeries:Minimally Invasive Right Subaxillary Vertical Thoracomy and Traditional Median Sternotomy

Simplified Minimally Invasive Beating Heart Technique for Redo Isolated Tricuspid Valve Surgery

Simplified, Minimally Invasive, Beating-Heart Technique for Redo Isolated Tricuspid Valve Surgery.

Long-term outcomes of minimally invasive concomitant mitral and tricuspid valve surgery with surgical ablation

Early and mid-term outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation induced by atrial fibrillation

Minimally Invasive Isolated Tricuspid Valve Repair after Left-Sided Valve Surgery: A Single-Center Experience.

Mid-term outcomes of isolated tricuspid valve surgery according to preoperative clinical and functional staging

Minimally Invasive Valve Replacement for Late Tricuspid Regurgitation after Left-Sided Valve Surgery

Minimally Invasive Isolated Tricuspid Valve Repair: the Trend for Redo Tricuspid Valve Surgery

Benefits Of A Right Anterolateral Minithoracotomy Rather Than A Median Sternotomy In Isolated Tricuspid Redo Procedures

Early and Mid-Term Outcomes of Isolate Mitral Valve Repair Through Minimal Invasive Versus Median Sternotomy Ap-Proach: a Propensity-Matched Analysis

Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring

Safety and efficacy of total thoracoscopic surgery for patients with tricuspid regurgitation and reduced right ventricular function after left heart valves replacement: a retrospective comparative study

Mid-term Outcomes of Transventricular Valvotomy Approach for Initial Treatment of Pulmonary Atresia with Intact Ventricular Septum

Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation

Mini-invasive Surgical Instruments in Transaortic Myectomy for Hypertrophic Obstructive Cardiomyopathy: a Single-Center Experience with 168 Cases

Isolated Reoperation for Tricuspid Regurgitation after Left-Sided Valve Surgery: Technique Evolution

Combined Mitral And Aortic Valve Procedure Via Right Mini-Thoracotomy Versus Full Median Sternotomy Insights From A Single-Center Study Of Propensity-Matched Data

Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes

Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center